Advertisement

Akute lymphatische Leukämien

  • D. Hoelzer
  • N. Gökbuget

Zusammenfassung

Während bei Kindern die akute lymphatische Leukämie (ALL) zu den häufigsten bösartigen Erkrankungen zählt, tritt sie im Erwachsenenalter eher selten auf. Die Inzidenz liegt bei 1/100000, wobei in der Altersgruppe > 55 Jahren ein leichter Anstieg zu beobachten ist. Die Erkrankungshäufigkeit insbesondere für bestimmte Untergruppen der ALL ist bei Männern höher als bei Frauen (1,4:1,0) [48].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Arlin Z, Feldman E, Mittelman A, Ahmed T, Cook P, Puccio C, Chun HG, Baskind P (1991) High dose short course mitoxantrone (M) with high dose cytarabine (HiDac) is safe effective therapy for acute lymphoblastic leukemia (ALL). Proc ASCO 10: 223Google Scholar
  2. 2.
    Barrett AJ, Horowitz MM, Bortin MM (1991) For the IBMTR. HLA-identical sibling bone marrow transplants for Ph’-chromosome positive acute lymphoblastic leukemia in first remission. Exp Haematol 19: 569Google Scholar
  3. 3.
    Bassan R (1992) Reinforced HEAV’D Therapy for Adult Lymphoblastic Leukemia: Improved Results and Revised Prognostic Criteria. Hematol Oncol 11: 169CrossRefGoogle Scholar
  4. 4.
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the Classification of the Acute Leukaemias. Br J Haematol 33: 451PubMedCrossRefGoogle Scholar
  5. 5.
    Berman E, Weiss M, Kempin S, Gee T, Bertino J, Clarkson B (1991) Intensive therapy for adult acute lymphoblastic leukemia. Semin Hematol 28: 72–75PubMedGoogle Scholar
  6. 6.
    Biondi A, Yokata S, Hansen-Hagge TE, Rosso V, Giudici G, Maglia O, Basso G, Tell C, Masera G, Bartram CR (1992) Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Analysis of Patients in Continuous Complete Remission or with Consecutive Relapse. Leukemia 6 (4): 282–288PubMedGoogle Scholar
  7. 7.
    Bleyer WA (1990) Central nervous system leukemia. In: Henderson ES, Lister TA, eds. Philadelphia: W.B. Saunders Company, 733–768Google Scholar
  8. 8.
    Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgstroem GH, Brandt L, Catovsky D, de la Chapella A, Dewald GW et al. (1986) Chromosomal Abnormalities Identify High-Risk and Low-Risk Patients with Acute Lymphoblastic Leukemia. Blood 67 (2): 415–420PubMedGoogle Scholar
  9. 9.
    Brennan C, Weisdorf D, Kersey J, Haake R, Ramsay N (1991) Bone marrow transplantation (BMT) for Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph’+ALL ). Proc ASCO 10: 222Google Scholar
  10. 10.
    Carella AM, Pollicardo N, Carlier P, Raffo MR, Podesta M, Dantini G, Congui A, Valbonesi M, Lercari G, Vitale V, Corvo P, Gallamini A, Parodi M (1992) „Normal“peripheral blood stem cells (PBSC) mobilization by myelosuppressive chemotherapy in very high-risk acute lymphoblastic leukemia (ALL) with cytogenetic translocations. Leuk Lymphoma 7: 19–21Google Scholar
  11. 11.
    Cassileth PA, Andersen JW, Hoagland HC, Mazza JJ, Bennett JM, Hahn RG, Tormey DC, O’Connell MJ. (1990) High-dose cytarabine therapy in adult acute lymphocytic leukemia. In: Gale RP, Hoelzer D, eds. Acute Lymphoblastic Leukemia. New York: Alan R Liss, 197–203Google Scholar
  12. 12.
    Clarkson B, Gaynor J, Little C, Berman E, Kempin S, Andreeff M, Gulati S, Cunningham I, Gee T (1990) Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic Leukemia. Haematol Blood Trans 33: 397Google Scholar
  13. 13.
    Cuttner J, Mick R, Budman DR et al. (1991) Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: A CALGB study. Leukemia 5: 425–431PubMedGoogle Scholar
  14. 14.
    Durrant IJ (1993) Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia. Br J Haematol 85: 84–92PubMedCrossRefGoogle Scholar
  15. 15.
    Elonen E, Almqvist A, Hänninen A, Jansson S-E, Järventie G, Koistinen P, Koivunen E, Lahtinen M (1991) Intensive tratment of acute lymphatic leukaemia in adults: ALL86 protocol. Haematologica 76 (Suppl 4): 133Google Scholar
  16. 16.
    Fenaux P, Lai JL, Miaux O, Zandecki M, Jouet JP, Bauters F (1989) Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol 71: 371–376PubMedCrossRefGoogle Scholar
  17. 17.
    Fiere D (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marroy transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastik Leukemia. J Clin Oncol 11: 1990–2001PubMedGoogle Scholar
  18. 18.
    Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, Varet B et al. (1993) Adult Acute Lymphoblastic Leukemia: A Multicentric Randomized Trial Testing Bone Marrow Transplantation as Postremission Therapy. J Clin Oncol 11 (10): 1990–2001PubMedGoogle Scholar
  19. 19.
    Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W et al. (1992) Treatment of Relapsed or Refractory Adult Acute Lymphocytic Leukemia. Cancer 69: 709–716PubMedCrossRefGoogle Scholar
  20. 20.
    Freund M, Heil G, Arnold R, Bartram C, Büchner Th, Diedrich H, Fonatsch C, Ganser A, Hiddemann W, Koch P, Link H, Löffler H, Ludwig WD, Machmeyer G, Schmitz N, Thiel E, Hoelzer D (1994) Treatment of relapsed or refractory adult acute lymphocytic leukemia. Ann Hematol 68, Suppl I: A10Google Scholar
  21. 21.
    Gaynor J, Chapman D, Little C, McKenzie S, Miller W, Andreff M, Arlin ZA, Berman E, Kempin S, Gee T, Clarkson B (1969) A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 199 Adults With Acute Lymphoblastic Leukemia: The Memorial Hospital Experience Since. J Clin Oncol 6 (6): 1014–1030Google Scholar
  22. 22.
    Haas OA, Mor W, Gadner H, Bartram CR (1988) Treatment of Ph-positive acute lymphoblastic leukemia with A-interferon. Leukemia 2: 555PubMedGoogle Scholar
  23. 23.
    Henslee-Downey Pi, Fleming D, Kryscio R, Romond E, Harder E (1991) Does mismatched bone marrow transplant (MMBMT) from related or unrelated donors offer successful salvage therapy for patients (pts) with relapsed acute lymphoblastic leukemia. Haematologica 76 (Suppl 4): 69Google Scholar
  24. 24.
    Hoelzer D (1991) High-Dose Chemotherapy in Adult Acute Lymphoblastic Leukemia. Sem Hematol 28(3) Suppl 4: 84–89Google Scholar
  25. 25.
    Hoelzer D (1991) Diagnosis and treatment of adult acute lymphocytic leukemia. In: Wiernik PH, Canellos GP, Keyle RA, Schieffer CA, eds. Neoplastic diseases of the Blood. New York: Churchill Livingstone, 253–274Google Scholar
  26. 26.
    Hoelzer D (1993) Aggressive Chemotherapy of ALL in Elderly Patients. Hematol Oncol 11 Suppl 1: 12–14Google Scholar
  27. 27.
    Hoelzer D (1993) Acute lymphoblastic leukemia — progress in children, less in adults. New Engl J Med 329: 1343–1344PubMedCrossRefGoogle Scholar
  28. 28.
    Hoelzer D (1994) Treatment of acute lymphoblastic leukemia. Semin Hematol 31: 1–15PubMedGoogle Scholar
  29. 29.
    Hoelzer D (1994) Therapy and prognostic factors in adult acute lymphoblastic leukemia. Bailliere’s Clinical Haematology 7 (2): 299CrossRefGoogle Scholar
  30. 30.
    Hoelzer D, Thiel E, Löffler H, Büchner T, Freund M, Ganser A, Heil G, Hiddemann W et al. (1990) Intensified Chemotherapy and Mediastinal Irradiation in Adult T-Cell Acute Lymphoblastic Leukemia. In: Acute Lymphoblastic Leukemia. Alan R. Liss, Inc, 221–229Google Scholar
  31. 31.
    Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B, Gökbuget N, Aydemir i.7 (1993) Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). Leukemia Suppl 2: 130–134Google Scholar
  32. 32.
    Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G (1992) The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia (in press)Google Scholar
  33. 33.
    Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G, Hiddemann W et al. (1992) The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia 6 Suppl 2: 175–177Google Scholar
  34. 34.
    Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B, Gökbuget N, Aydemir GAASG (1993) Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). Leukemia 7 (Suppl 2): S 130—S 134Google Scholar
  35. 35.
    Hooberman A, Westbrook C, Spino C, Wurster-Hill D, Sobol R, Davey F, Larson R (1991) Clinical significance of molecular detection of the BCR-ABL fusion gene in acute lymphoblastic leukemia (ALL): a Cancer and Leukemia Group B ( CALGB) study. Proc ASCO 10: 222Google Scholar
  36. 36.
    Horowitz MM; Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett J, Büchner T, Freund M, Heil G, Hiddemann W, Kolb H-J, Löffler H, Marmont AM, Maschmeyer G, Rimm AA, Rozman C, Sobocinski KA, Speck B, Thiel E, Weisdorf DJ, Zwaan FE, Bortin MM (1991) Chemotherapy compared with bone marrow transplantation for adult with acute lymphoblastic leukemia in first remisson. Ann Hematol 115: 13–18Google Scholar
  37. 37.
    Kantarjian H, Estey E, O’Brien S, Robertson LB, Beran M, Pierce S, Keating M (1992) Granulocyte-colony stimulating factor (G-CSF) supportive care following intensive chemotherapy consolidation in acute lymphocytic leukemia (ALL) in first remission. Blood 80 (Suppl 1): 112 aGoogle Scholar
  38. 38.
    Kantarjian HM, Walters RS, Keating MJ, Smith TL, O’Brien S, Estey EH, Huh YO, Spinolo J et al. (1990) Results of the Vincristine, Doxorubicin, and Dexamethasone Regimen in Adults With Standard-and High-Risk Acute Lymphocytic Leukemia. J Clin Oncol 8: 994–1004PubMedGoogle Scholar
  39. 39.
    Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB, Freireich EJ (1988) Identificaton of Risk Groups for Development of Central Nervous System Leukemia in Adults with Acute Lymphocytic Leukemia. Blood 72 (5): 1784–1789PubMedGoogle Scholar
  40. 40.
    Linker CA, Levitt LJ, O’Donnell M, Forman SJ, Ries CA (1991) Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 78: 2814–2822PubMedGoogle Scholar
  41. 41.
    Lluesma-Gonalons M, Pavlovsky S, Santarelli MT, Eppinger-Helf M, Bavea ED, Corrado C, Carnot J et al. (1991) Improved results of an intensified therapy in adult acute lymphocytic leukemia. Annals of Oncology 2: 33–39PubMedGoogle Scholar
  42. 42.
    Ludwig WD, Harbott J, Rieder H, Bartram CR, Maurer J, Becher R, Heinze B, Gassmann W, Drexler HG, Martin M, Sperling C, Völkers B, Reiter A, Ritter J, Hiddemann W, Büchner T, Löffler H, Fonatsch C, Hoelzer D, Riehm H, Thiel E (1994) Incidence, Biologic Features and Treatment Outcome of Myeloid-AntigenPositive. Acute Lymphoblastic Leukemia (My+ALL. In: Büchner et al., ed. Acute Leukemias I V. Prognostic Factors. Springer-Verlag, Berl in HeidelbergGoogle Scholar
  43. 43.
    Ludwig WD, Maurer J, Bartram CR et al. (1991) Bedeutung zellbiologischer Merkmale von Leukämiezellen für die Entwicklung risikoadaptierter Therapiestrategien bei akuten lymphatischen Leukämien (ALL). Wissenschaftswoche 1991 Universität Steglitz der Freien Universität Berlin 58–60Google Scholar
  44. 44.
    Ludwig WD, Raghavachar A, Thiel E (1994) Immunophenotypic classification of acute lymphoblastic leukemia. Bailliere’s Clinical Haematology 7 (2): 235CrossRefGoogle Scholar
  45. 45.
    Marie J-P, Zittoun R, Sikic BI (1991) Multidrug resistance (mdr-1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 586–592PubMedGoogle Scholar
  46. 46.
    Martin H, Atta J, Bruecher J, Claudé R, Elsner S, Hoelzer D (1993) Minimal residual disease in patients with Ph-positive acute lymphoblastic leukemia before and after autologous bone marrow transplantation. Exp Hematol 21: 1065Google Scholar
  47. 47.
    Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig WD, Aydemir C, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR (1991) Detection of chimeric BCR-ABL genes in acute lymphoblastic leukemia by the polymerase chain reacton. Lancet 337: 1055PubMedCrossRefGoogle Scholar
  48. 48.
    McKinney Pa, Alexander FE, Cartwright RA, Ricketts TJ (1989) The Leukemia Research Fund Data Collection Study: Descriptive Epidemiology of Acute Lymphoblastic Leukemia. Leukemia 3 (12): 880–885Google Scholar
  49. 49.
    Meloni G, Foa R, Tosti S, Vignett M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F (1992) Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study. Leukemia 6: 780–785PubMedGoogle Scholar
  50. 50.
    Ohyashiki K, Ohyashiki JH, Tauchi T, Fujieda H, Hojo H, Ohtaka M, Daito M, Nakazawa S, Toyama K (1991) Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a pilot study which raises important questions. Leukemia 5: 611–614PubMedGoogle Scholar
  51. 51.
    Ottman OG, Hoelzer D, Gracien E, Kelly K, Ganser A, Reutzel R, Lipp T, Busch FW, Schwonzen M, Wandt H, Heil G, Koch P, Heyll A, Meyer P, Pentz M, Peter S, Diedrich H, Kolbe K (1993) Concomitant R-metHuG-CSF (Filgrastim) and intensive chemoradiotherapy as induction treatment in adult ALL: a randomized multicenter Phase III trial. Blood 82 (Suppl 1): 193 aGoogle Scholar
  52. 52.
    Patte C, Leverger G, Rubie H, Bertrand Y, Coze C, Méchinaud F, Lutz P, Michon J, Baruchel A, Courbon BS (1993) High cure rate in B-cell (Burkitt’s leukemia in the LMB 89 protocol of the SFOP (French Pediatric Oncology Society). Proc ASCO 12: 317Google Scholar
  53. 53.
    Potter MN, Cross NCP, van Dongen JJM, Saglio G, Oakhill A, Bartram CR, Goldman LM (1993) Molecular evidence of minimal residual disease after treatment for leukemia and lymphoma: an updated meeting report and review. Leukemia 7: 1302–1314PubMedGoogle Scholar
  54. 54.
    Reiter A (1994) Therapy of B-cell acute lymphoblastic leukaemia in childhood: The BFM experience. Bailliere’s Clinical Haematology 7 (2): 321CrossRefGoogle Scholar
  55. 55.
    Rieder H, Ludwig WD, Gassmann W, Thiel E, Löffler H, Hoelzer D, Fonatsch C (1993) Chromosomal Abnormalities in Adult Acute Lymphoblastic Leukemia: Results of the German ALL/AUL Study Group. Recent Res Cancer Res 131: 133CrossRefGoogle Scholar
  56. 56.
    Rohatiner AZS, Bassan R, Battista R, Barnett MJ, Gregory W, Lim J, Amess J, Oza B, Barbui T (1990) High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukemia. Br J Cancer 62: 454–458PubMedCrossRefGoogle Scholar
  57. 57.
    Schiffer CA, Larson RA, Bloomfieed CD (1992) Cancer and leukemia group B (CALGB) studies in adult acute lymphocytic leukemia. Leukemia 6 (suppl 2): 171–174PubMedGoogle Scholar
  58. 58.
    Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV (1991) Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 5: 196–199PubMedGoogle Scholar
  59. 59.
    Stryckmans P, de Witte T, Marie JP, Fillet G, Peetermans M, Bury J, Muus P, Andrien JM, Hayat M, Jaksic B, Labar B, Debusscher L, Solbu G, Suciu S, Zittoun R (1992) Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). Leukemia 6 (Suppl 2): 199–203PubMedGoogle Scholar
  60. 60.
    Stryckmans P, Debusscher L (1991) Chemotherapy of adult acute lymphoblastic leukaemia. Baillère’s Clinical Haematology 4: 115–130CrossRefGoogle Scholar
  61. 61.
    Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762). Blood 80: 2983–2990PubMedGoogle Scholar
  62. 62.
    Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, Azar C, Garl S, Benson L (1993) Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia 7: 1236–1241PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • D. Hoelzer
  • N. Gökbuget

There are no affiliations available

Personalised recommendations